Skip to content

Implant-supported Fixed Dental Prostheses (FDPs) With Cantilever Extension

Clinical and Radiographic Outcomes of Implant-supported Full-ceramic Partial Fixed Dental Prostheses With Cantilever Extension: A Proof of Principle Study With a Follow-up of at Least 1 Year

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05676268
Enrollment
35
Registered
2023-01-09
Start date
2023-01-02
Completion date
2023-12-31
Last updated
2026-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implant Failed, Peri-Implantitis, Prosthesis Failure

Brief summary

To report the clinical and radiographic outcomes of implant-supported fixed dental prostheses with full-ceramic cantilever extensions (FDPCs) after a function time ≥ 12 months.

Detailed description

Patients with full ceramic FDPCs in anterior and posterior areas will be clinically and radiographically re-evaluated. Mesial and distal radiographic marginal bone levels (mBLs) from baseline (i.e. delivery of FDPC) to the follow-up examination were calculated and compared between implant surfaces adjacent to and distant from the cantilever extension. Implant survival rate (%), pocket probing depth (PPD), presence/ absence of bleeding on probing (BoP) and presence/absence of mechanical/technical and biological complications were recorded.

Interventions

PROCEDUREImplant-supported fixed dental prostheses with cantilever extension

Healthy patients in need of replacement of missing teeth with dental implants supporting partial fixed dental prostheses with cantilever extensions

Sponsors

University of Bern
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients aged ≥18 years * Written informed consent * Patients with systemic health or controlled medical conditions * Patients with healthy or treated periodontal conditions * Patients enrolled in regular supportive periodontal therapy (SPT) * Patients without clinical signs of bruxism and/or oral parafunctions * 2 osseointegrated dental implants in the canine or posterior areas of maxilla and mandible following transmucosal placement and healing of 3-6 months * Tissue level solid-screw implants with a sand-blasted and acid- etched (SLA) surface with an endosseous diameter of 3.3, 4.1 or 4.8 mm, a length of 8, 10 or 12 mm, a shoulder diameter of 4.8 mm and a supracrestal machined neck with a height of 1.8 or 2.8 mm (Straumann® Dental Implant System, Institut Straumann AG, Basel, Switzerland) * Full-ceramic * Utilization of prefabricated titanium abutments * Cemented (3M™ ESPE Ketac™ Cem, Seefeld, Germany) or screw-retained fixed dental prostheses with a mesial or distal cantilever extension (FDPCs) * Cantilever extension corresponding to 1 premolar unit (i.e., 6-7 mm) * Absence of occlusal contacts or guidance on the cantilever extension at baseline * Opposing dentition consisting of natural teeth or fixed or removable prosthetic restorations * Availability of a periapical radiograph at baseline (i.e. FDPC delivery) * Availability of PPD measurements (mm) taken at baseline at 4 sites/implant with a graduated Michigan periodontal probe (Deppeler SA, Rolle, Switzerland) * Availability of BoP measurements (%) (Lang et al., 1986) taken at baseline at 4 sites/implant with a graduated Michigan periodontal probe (Deppeler SA, Rolle, Switzerland).

Exclusion criteria

* Untreated or active periodontal diseases * Immediate implant placement (i.e., Type I implant placement according to Hämmerle et al., 2004) * FDPCs in the aesthetic zone (i.e., replacement of maxillary or mandibular incisors) * FDPCs supported by hollow-screw and hollow-cylinder implants

Design outcomes

Primary

MeasureTime frameDescription
Implant survival rate12 monthsPercentage of dental implants present at follow-up visit

Secondary

MeasureTime frame
Peri-implant marginal bone level changes12 months
Number of technical complications12 months
Number of mechanical complications12 months
Number of Biological complications12 months

Countries

Switzerland

Contacts

PRINCIPAL_INVESTIGATORAndrea Roccuzzo

University of Bern

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026